Our  leadership

Management

ANDREW WEISS, MBA  President & Chief Executive Officer

Andrew Weiss joined ReCor Medical in April 2013.

Mr. Weiss brings over 20 years experience in the Medical Device Industry, starting with global management responsibilities at GE Medical Systems. Mr. Weiss left GE to become Vice President of Sales & Marketing at Marquette Medical Systems. Following Marquette, Mr. Weiss became President & CEO of Vital Images, a company he took public in 1996. Mr. Weiss then joined Medtronic as VP & General Manager of its Surgical Navigation Systems business, following which he became VP & General Manager of the Medtronic Neurological business. Prior to joining ReCor Medical, Mr. Weiss served as President & CEO of CoAxia, Inc. Mr. Weiss is a graduate of the Massachusetts Institute of Technology with a degree in mechanical and electrical engineering and has an MBA from the Columbia University Graduate School of Business.

MANO IYER, MBA   Founder & Chief Operating Officer

Mano Iyer is a founder of ReCor Medical.

Mr. Iyer served as Entrepreneur-In-Residence at Sofinnova Partners, a life science venture capital firm, in Paris, France since 2008. Mr. Iyer has spent the last 20 years working in the Medical Device Industry in various engineering, operational, and investment roles in the US, France, Germany, Switzerland, the Czech Republic, and the Netherlands, for public and private enterprises. He is a co-founder of Contract Medical International in Germany and a former Investment Manager at MD Start, a European-based medical device accelerator. Mr. Iyer has a BS in Mechanical Engineering from the Rochester Institute of Technology and an MBA from the Stanford Graduate School of Business.

MATTHEW J. FRANKLIN, MBA    Chief Financial Officer

Matthew Franklin joined ReCor Medical in June 2015.

Mr. Franklin has been CFO of numerous venture-backed companies including most recently serving as CFO of myoscience (therapeutics/aesthetics) for six years. He specializes in helping Pre-IPO companies get through initial commercialization. In 2000, he co-founded, CFO Connection, a financial services firm that assists technology and medtech companies in successfully building their businesses. Prior to CFO Connection he was ACLARA BioSciences’ (medtech) top financial officer for four years. Earlier in his career he was Co-Founder and CFO at BioLumin Corporation (sold to GE Healthcare) and held senior financial positions at VeloBind (Manufacturing) and Precision Echo (Defense Manufacturer), both public companies. Mr. Franklin received a BS in Business from the University of Southern California and an MBA from Santa Clara University.

NEIL C. BARMAN, MD    Chief Scientific Officer

Neil C. Barman joined ReCor Medical in November 2017.

Prior to joining ReCor, Dr. Barman co-founded AblaCare, a start-up medical device company focused on infertility due to polycystic ovary syndrome. Prior to this, Dr. Barman was an early employee and part of the senior management team at Ardian. Ardian pioneered the field of catheter-based renal denervation and was acquired by Medtronic in January 2011. Previously, Dr. Barman led the clinical/medical team at Concentric Medical that developed the first FDA approved line of embolectomy catheters for ischemic stroke. He started his medical device career at Radiant Medical investigating catheter-based cooling for heart attack and stroke. Dr. Barman graduated Phi Beta Kappa with a B.S. in Biology from Stanford University. He earned his M.D. from Northwestern University Medical School. During medical school, Dr. Barman also did coursework at the Kellogg School of Management.

HELEN REEVE-STOFFER, Ph.D  Vice President, Clinical Affairs

Helen Reeve-Stoffer joined ReCor Medical in June 2013.

Dr. Reeve-Stoffer has more than 15 years of experience of global clinical and Medical Affairs program development in the medical device industry preceded by an additional 9 years in academic research and teaching. Most recently Dr. Reeve-Stoffer served as CRM Clinical Director for New Product Development and Low Voltage platforms for Boston Scientific Inc. where she was responsible for the pre and post-launch clinical evidence and regulatory program strategies. She also held the position of International Director of Medical Affairs and Education at Cameron Health BV and prior to that had several US and International-based clinical positions for Guidant Corporation including project management, technical field support for all study phases and the development of country-specific clinical business strategies. She began her academic career as an Assistant Professor at the University of Minnesota. Dr. Reeve-Stoffer earned her PhD and BSc in Pharmacology at the University of Leeds, Leeds UK.

LESLIE COLEMAN, DVM, MS, DACLAM  Vice President, Regulatory & Medical Affairs

Leslie Coleman joined ReCor Medical in May 2013.

Dr. Coleman has more than 15 years of experience in the medical device industry in medical affairs, preclinical and clinical research, and over 10 years of veterinary medicine. Prior to joining ReCor Medical, Dr. Coleman served as Director, Medical Affairs at Abbott Vascular Structural Heart. Previously, Dr. Coleman was Director, PreClinical Research at Abbott Vascular and Guidant Corporation where she was a key contributor towards numerous research and development projects to treat coronary artery disease. Dr. Coleman has contributed towards the development of several drug eluting stent platforms through PMA submission, FDA Advisory panel meeting and PMA approval. Dr. Coleman received a Doctorate of Veterinary Medicine at the University of California, Davis, a Masters of Science in Toxicology from the Massachusetts Institute of Technology, and is a Diplomate of the American College of Laboratory Animal Medicine.

DAVE HAUGAARD  Vice President, Operations

Dave Haugaard joined ReCor Medical in September 2018.

Mr. Haugaard brings over 20 years of experience in operational leadership in the development and commercialization of innovative Medical Devices for underserved patients. Previously, Mr. Haugaard was Vice President of Operations at Elixir Medical, a start-up coronary drug eluting stent company where he developed and commercially launched numerous bioabsorbable and metallic stent systems. Prior to this, he was Senior Director of Operations at Conor Medsystems, a drug-eluting stent company acquired by Johnson and Johnson in February 2007 and Director of Operations for Broncus Technologies, which developed devices for interventional pulmonology. During his career Mr. Haugaard has led both domestic and international operations teams from development and through commercialization. He received his BS in Mechanical Engineering from Oregon State University.

FAISAL KHAN  Vice President, Marketing

Faisal Khan joined ReCor Medical in January 2019.

Mr. Khan has over 18 years experience spread across management consulting, technology and healthcare. Within medical devices, Mr. Khan as built and led high performing marketing teams in cardiovascular, peripheral vascular, and neurovascular markets. Mr. Khan started his career as a management consultant at PricewaterhouseCoopers and then IBM, leading consulting projects exceeding $1 billion in revenue at clients such as Pfizer. Mr. Khan went on to work in positions of increasing leadership at companies such as Cordis, Abbott Vascular and Stryker Neurovascular, managing global launches of both line extensions and disruptive innovations in the access, intervention and closure categories. Mr. Khan has a Bachelor’s degree in Systems Engineering from the University of Virginia, and an MBA from the University of Chicago Booth School of Business.

DAVID KIM  Vice President, Quality Affairs

David Kim joined ReCor Medical in June 2015.

Mr. Kim has 20 years experience with increasing responsibility in quality assurance systems and engineering. Mr. Kim began his quality career at Perclose following the acquisition by Abbott Laboratories, where he lead the site implementation of corporate quality and compliance directives. Following that experience, he worked at several rapidly growing medical device companies including Conor MedSystems where he was part of evolving the quality system to meet the demands of an expanding organization while maintaining a collaborative and innovative culture of compliance. More recently, Mr. Kim has been the first quality employees at several early stage companies including Moximed and Altura Medical, where he was responsible for rapidly establishing the quality system and obtaining ISO certification. Mr. Kim is a graduate of the University of Southern California with a Bachelor of Science in Biomedical Engineering.

ANDREW WU   Vice President, R&D

Andy Wu joined ReCor Medical in July 2018.

Mr. Wu has 20 years of experience in medical device product development. He has worked on devices in the fields of interventional cardiology, electrophysiology, pulmonology, and women’s health, and has taken a number of them from early concept phase through clinical or commercial launch. Immediately prior to joining ReCor, Mr. Wu was a co-founder of Ziva Medical and an independent consultant conducting R&D for seed-stage startup companies. He was also an early employee and Director of R&D at Ardian. As the core team and system technical leader, Mr. Wu and the Ardian team led the pioneering research and release of the first catheter-based systems ever used to perform renal denervation as a treatment for hypertension. In addition to holding management roles at other device startups, Mr. Wu was also a process and R&D engineer on market-leading products at Guidant Corporation and Medtronic. Mr. Wu received a BS in Mechanical Engineering from the University of Michigan and a MS in Mechanical Engineering from the University of Illinois.

BOARD OF DIRECTORS

NORIKO TOJO,  Chairman

Noriko Tojo was appointed chairman of the board of directors of ReCor Medical in July 2018.

Mrs. Tojo is President and Representative Director of Otsuka Medical Devices Co., Ltd. and an Executive Director of Otsuka Holdings Co., Ltd., which she joined in 2008, initially as Managing Director in charge of business development. Prior to joining Otsuka, Mrs. Tojo was a Director of Intel Capital in Tokyo, where she focused on advanced technology-related investments. She joined Intel Capital in 2004 from McKinsey & Company, where she was an Engagement Manager advising major Japanese and US corporations on technology strategy and mergers and acquisitions. Mrs. Tojo started her career as an investment banker with Goldman Sachs in Tokyo. Mrs. Tojo holds a Bachelor of Laws (LL.B.) from the University of Tokyo and an MBA from Harvard Business School.

 

MANO IYER 

See above in MANAGEMENT.

 

KAZUMICHI KOBAYASHI

Kazumichi Kobayashi, R.Ph., is a Senior Vice President of Otsuka Holdings Co., Ltd. in its Business Development and Planning Department. He is also an Executive Director and board member of Otsuka Medical Devices Co., Ltd. Prior to joining Otsuka Holdings, Mr. Kobayashi was on assignment  as Senior Research Fellow to the Office of Pharmaceutical Industry Research (OPIR) at JPMA from April 2012 to March 2015. Prior to OPIR, he was a Senior Vice President and co-head of Otsuka’s Pharmaceutical Business Division as well as head of Clinical Development, Regulatory Affairs, and Quality Assurance at Otsuka Pharmaceutical. Concurrently, he served as CEO of Otsuka Maryland Research Institute and from 2007 as the first CEO of Otsuka Pharmaceutical Development and Commercialization Inc. (Princeton). He joined the Regulatory Affairs Department of Otsuka Pharmaceutical Co., Ltd. in 1982 and became Director for Regulatory Affairs and Quality Assurance in 2000.

 

ANDREW WEISS 

See above in MANAGEMENT.

 

Contactez-nous        

RECOR MEDICAL NORTH AMERICA
1049 Elwell Court
Palo Alto, CA 94303
+1 650 542 7700

info@recormedical.com

RECOR MEDICAL UK
Office #33, Innovation House, Innovation Way
Discovery Park
Sandwich, Kent CT13 9FF
+44 1304 806862

info@recormedical.com